Doctors in Taiwan have cited concerns over costs, testing delays, and potential interactions for the low prescription of oral COVID-19 drugs, which have only been used to treat just over 3,000 people despite daily case numbers surpassing 50,000.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan's China Airlines, Boeing ink deal for 14 777X jets
05/09/2025 06:19 PM - Society
Chiayi man sentenced to 14.5 year for killing neighbor over noise dispute
05/09/2025 06:17 PM - Business
TSMC reports record monthly revenue in April
05/09/2025 05:34 PM - Business
U.S. dollar closes higher on Taipei forex market
05/09/2025 04:13 PM - Politics
Taiwan medical groups urge WHO to invite Taiwan to WHA as observer
05/09/2025 03:12 PM